Julia Lawless/Antonia Ferrier (Hatch), (202) 224-4515
John Hart (Coburn), (202) 228-5357
Michelle Dimarob/Sarah Swinehart (Ways & Means), (202) 226-4774
Senate Finance, House Ways & Means Committee Members Question Whether CMS is Fully Protecting Medicare from Waste, Fraud, & Abuse
Lawmakers Press for Answers on Agency’s Oversight Efforts in Identifying Bad Actors within Medicare Program
WASHINGTON – – In a letter today, Senate Finance Committee Ranking Member Orrin Hatch (R-Utah) and Committee member Tom Coburn (R-Okla.) along with House Ways and Means Health Subcommittee Chairman Wally Herger (R-Calif.) and Oversight Subcommittee Chairman Charles Boustany, M.D. (R-La.), asked the Acting Administrator of the Centers for Medicare & Medicaid Services (CMS), Marilyn Tavenner, whether the agency is fully utilizing its resources to safeguard the Medicare program from waste, fraud and abuse.
Specifically, the lawmakers requested information regarding the agency’s efforts to identify “nominee owners” and the type of fraud perpetrated by individuals and organizations establishing false storefronts and “shell companies” – paper-only firms with no real operations.
“On March 7, 2012, the Department of Justice (DOJ) indicted an individual for allegedly swindling $20 million from the Medicare program over a five-year period by establishing two home health agencies using a nominee owner,” wrote the lawmakers. “This indictment, along with the other examples cited in this letter, demonstrate that CMS’s provider screening efforts are still not effectively safeguarding the Medicare program from individuals intent on committing fraud within the Medicare program and that CMS should revise its screening efforts to address nominee owners.”
The U.S. Senate Finance and House Ways and Means Committees have jurisdiction over the Medicare program.
Below is the full text of the letter:
April 2, 2012
Marilyn Tavenner, Acting Administrator
Center for Medicare & Medicaid Services
200 Independence Avenue, S.W.
Washington, DC 20201
Dear Acting Administrator Tavenner:
As members of both House and Senate Committees overseeing the Medicare program, we have a responsibility to conduct oversight and ensure that the Centers for Medicare & Medicaid Services (CMS) is utilizing all possible resources and authorities to protect the Medicare program from fraud, waste, and abuse. It is in this role that we are writing to request additional information regarding CMS’s efforts to identify “nominee owners” and the type of fraud perpetrated by individuals and organizations establishing false storefronts and “shell companies” – paper-only firms with no real operations.
“On March 7, 2012, the Department of Justice (DOJ) indicted an individual for allegedly swindling $20 million from the Medicare program over a five-year period by establishing two home health agencies using a nominee owner. This indictment, along with the other examples cited in this letter, demonstrate that CMS’s provider screening efforts are still not effectively safeguarding the Medicare program from individuals intent on committing fraud within the Medicare program and that CMS should revise its screening efforts to address nominee owners.
As you know, a nominee owner does not identify himself as an owner, but in fact exercises ownership and control of an entity. Thus, the true owner of the entity gives someone else limited authority to act on behalf of an entity, usually for a limited period of time, and usually during the initial formation of the entity. In fact, the Internal Revenue Service (IRS) does not authorize the use of nominees to obtain an employer identification number (EIN), and the DOJ recently convicted  several individuals after they installed nominee Presidents to hide their control of five durable medical equipment companies that submitted fraudulent claims to Medicare. The Department of Health and Human Services’ Office of Inspector General (HHS-OIG) has expressed concerns regarding the use of nominee owners and recommended that CMS take aggressive action to identify them. Thus far, it does not appear that CMS has addressed the concept of nominee owners, false storefronts, and shell companies in any of its enrollment regulations or its Provider Screening statement of work.
Accordingly, to address our concerns about the ongoing Medicare and Medicaid fraud, were request that CMS:
1. Describe CMS’s efforts to identify and detect nominee owners in the Medicare and Medicaid programs since publication of the Medicare, Medicaid, and CHIP screening rule on February 2, 2011.
2. Explain whether or not CMS (directly or through the Medicare enrollment contractors) collaborates with the IRS, HHS-OIG, the Social Security Administration, the Department of Homeland Security and/or the DOJ to verify information regarding individuals listed as a prospective owner of a provider or supplier in the Medicare, Medicaid and CHIP programs.
3. Explain whether or not CMS has implemented payment caps to protect the Medicare program from “bust-out” schemes such as those described in the Reuters article cited below..
4. Provide a list of the safeguards (i.e., use of smart card technology, authentic token, or multi-factor verification technology) currently utilized by the Medicare enrollment contractors to verify the identity of an individual practitioner, owner, or authorized/delegated official during the initial enrollment process, change of information, or enrollment revalidation submission.
5. Describe the process used by CMS to determine which categories of providers and suppliers are deemed “high risk” and explain why non-physician owned clinics are currently viewed as “low risk” by CMS.
In closing, we share your goal of ensuring that the Medicare, Medicaid, and CHIP programs have appropriate procedures in place to confirm the ownership interest of participating providers and suppliers. As such, we would like to better understand the steps CMS is taking to identify nominee owners and false storefronts prior to those individuals/entities ever gaining entry into the Medicare, Medicaid or CHIP programs. We appreciate your efforts in responding to this request and ask that you respond by April 20, 2012.
Next Article Previous Article
- Wyden Statement on Supreme Court Fulton v. City of Philadelphia Decision
- Wyden, Crapo, Cornyn, Warner, Daines, Stabenow Introduce Bill to Boost Domestic Manufacturing of Semiconductors
- WYDEN, CASSIDY: Allow Americans With Disabilities to Work Without Worry
- Wyden Statement on Supreme Court ACA Decision
- Wyden Statement at Finance Committee Hearing on President Biden’s Fiscal Year 2022 Budget